TELIX PHARMACEUTIC earnings per share and revenue

TLX1/N earnings per share for the last semiannual are 0.65 MXN whereas the estimation was 0.85 MXN which accounts for -23.61% surprise. Company revenue for the same period amounts to 3.26 B MXN despite the estimated figure of 3.24 B MXN. Estimated earnings per share for the next semiannual are 0.62 MXN, and revenue is expected to reach 3.81 B MXN. Also watch annual changes over time to get a bigger picture of TLX1/N earnings per share and revenue dynamics.